Serum concentrations of cancer antigen 125 (CA 125) were determined for 373 patients with
various liver diseases: 57 with acute hepatitis, 57 with chronic hepatitis, 244 with liver …

• Objectives: To determine the association between elevated levels of serum cancer antigen
(CA) 125 and liver disease and to explore the possibility that CA 125 is produced by the …

Abstract Background and Aim: Serum cancer antigen (CA) 125 elevation has been reported
in patients with liver disease, but it is poorly characterized. The present study aimed to …

CA 125 is a tumour marker usually used in the monitoring of ovarian carcinoma patients.
This study was performed to evaluate the behaviour of CA 125 in 159 patients with benign …

OBJECTIVE: Cancer antigen 125 (CA 125) is a high molecular mass glycoprotein, usually
used for monitoring the course of epithelial ovarian cancer. Recently it has been shown that …

The presence of CA 125, an ovarian cancer‐associated antigen, was assessed in serum
and ascites from patients with ovarian cancer (n= 47), hepatocellular carcinoma (n= 21), and …

The presence of Ca 125, an ovarian cancer-associated antigen, was assessed in serum
from patients with liver diseases with (n= 26) and without (n= 26) ascites. Abnormal levels of …

ABSTRACT A study of 347 patients with gastrointestinal diseases revealed elevation of
CA125 in sera of 63% of patients with pancreatic carcinoma, 46% of patients with carcinoma …

Objectives: High serum cancer antigen (CA) 125 levels have been shown to be present in
patients with ovarian carcinoma, nongynecological cancers, and some benign diseases and …

Results An elevated serum CA 242 concentration (> 20 U/mL) was found in 30 out of 40
(70%)(mean; 2163+/-838 U/mL) patients with pancreas cancer, in 11 out of 15 patients with …